Sort by
Refine Your Search
-
Listed
-
Field
-
and evaluation of pathogen-selective, enzyme-activated carrier chemistry and will work closely with computational collaborators and other team members on iterative design-synthesize-test workflows
-
develop and apply cell-based therapeutic strategies, including CAR T approaches, to target pathogenic cell states and improve tissue repair in diseases involving muscle damage, fibrosis, ischemia, and
-
health. Basic science discoveries made using a variety of human and pathogen-derived proteins, designed, expressed and purified by a collaborative DHVI team have contributed to the identification
-
for Duchenne muscular dystrophy (DMD), funded by NIH R21 project (1R21AR087645-01). The project aims to target pathogenic inflammatory and fibrotic stromal cell populations that impair muscle regeneration in DMD
-
develop and apply cell-based therapeutic strategies, including CAR T approaches, to target pathogenic cell states and improve tissue repair in diseases involving muscle damage, fibrosis, ischemia, and
-
infectious diseases that impact global health. Basic science discoveries made using a variety of human and pathogen-derived proteins, designed, expressed and purified by a collaborative DHVI team have